Increased Susceptibility to OxidantMediated Tissue Injury and Peritoneal Fibrosis in Acatalasemic Mice

Introduction
Peritoneal dialysis (PD) is an established treatment for patients with end-stage renal diseases. However, longterm PD is associated with a progressive increase in the thickness and hyperpermeability of the peritoneal membrane. Peritoneal fibrosis is one of the major complications leading to the loss of peritoneal function in patients undergoing PD. Its progression underlies the subsequent onset of the most serious complication during long-term PD therapy: encapsulating peritoneal sclerosis. New PD solutions with neutral pH or low glucose degradation products (GDPs) have recently been introduced into clinical use; however, the effect of these new fluids on the prevention of peritoneal fibrosis is still unclear. Moreover, the development of encapsulating peritoneal sclerosis disrupts effective PD therapy and is associated with a high mortality [1] .
The degree of oxidative stress and the severity of subsequent tissue injury may depend on an imbalance between excessive production of reactive oxygen species (ROS) and antioxidant defense within the peritoneum. Catalase is a major enzyme that catalyzes the decomposition of hydrogen peroxide (H 2 O 2 ) and plays a role in cellular antioxidant defense mechanisms [2] . This enzyme is localized in the matrix of peroxisomes in mammalian cells and is involved in two different types of enzymatic reaction: the catalatic activity (2H 2 O 2 ] O 2 + 2H 2 O) and the peroxidatic activity (H 2 O 2 + AH 2 ] A + 2H 2 O). Catalase, therefore, limits the accumulation of H 2 O 2 , which is generated by various oxidases in tissue and serves as a substrate for the Fenton reaction to generate the highly injurious hydroxyl radicals. Takahara [3] first documented genetic defects of catalase in Japanese patients who exhibited a deficiency of blood catalase activity (acatalasemia). The short-term clinical manifestations in acatalasemic patients after exposure to H 2 O 2 or infection with peroxide-generating bacteria such as streptococci and pneumococci appear predominantly in the mouth, thus resulting in an increase in the activity of phagocytic cells at the inflamed sites. At present, however, there is no information about the regulation of the antioxidant defense system including catalase in the peritoneum in health or disease conditions. This study is based on the hypothesis that a functional catalase deficiency renders the peritoneum more susceptible to oxidant tissue injury and the effect of dysregulation of the antioxidant systems on peritoneal fibrosis was investigated utilizing an acatalasemic mouse strain.
Materials and Methods
Experimental Protocol
The experiments described in this study were conducted in male wild-type mice (C3H/AnLCs a Cs a ) and male homozygous acatalasemic mutant mice (C3H/AnLCs b Cs b ) weighing 25 8 3 g at the age of 7 weeks. They were housed in a light-and temperature-controlled room in the Department of Animal Resources, Advanced Science Research Center, Okayama University. They had free access to laboratory chow (MF diet; Oriental Yeast Co.
Ltd., Tokyo, Japan) and tap water in standard rodent cages. Peritoneal fibrosis was induced by intraperitoneal injection of 0.15 or 0.25% chlorhexidine gluconate (CG) in 15% ethanol dissolved in saline (Maruishi Seiyaku, Osaka, Japan) at a volume of 0.3 ml every other day over a period of 14 days, as described previously, with some modifications [4, 5] . In the control group of mice, the same volume of 15% ethanol in saline was injected intraperitoneally every other day. Each group consisted of 10 mice. The concentration and interval for CG injections were selected based on pilot studies conducted to determine the effects of different doses on the thickness of submesothelial area and mortality. The experimental protocol was reviewed by the Ethics Review Committee for Animal Experimentation of the Okayama University Graduate School and approved by the Committee.
Catalase, Glutathione Peroxidase (GPX), and Superoxide Dismutase (SOD) Activity in Peritoneal Tissue
After harvesting peritoneal tissue from either wild-type or acatalasemic mice, the samples were immediately snap frozen in liquid nitrogen and stored at -80 ° C until assayed. The catalase activity was determined by measuring the removal rate of 70 M H 2 O 2 based on a method described previously [6, 7] . GPX and SOD activities were measured as described previously [6, 8] .
Light Microscopic Studies
Formalin-fixed, paraffin-embedded 3-m sections were assessed using Azan-Mallory stain [6, 9] . Each tissue section was observed by means of an Olympus BX51 light microscope (Olympus, Tokyo, Japan) with a high-resolution digital camera system (Penguin 600CL; Pixera Corp., San Jose, Calif., USA). The thickening of the submesothelial compact zone above the abdominal muscle layer was defined as the peritoneal thickness, as described previously [4, 5] . Measurement of the peritoneal thickness was performed by image analysis at ! 100 original magnification using a MicroAnalyzer program (version 1.1; Nippon Poladigital Co., Tokyo). In each image, the peritoneal thickness was measured at ten randomly selected and nonoverlapping points. Peritoneal fibrosis was defined as a submesothelial compact zone thickness exceeding 15 m based on the highest value recorded for the control subjects not receiving CG injections. The peritoneal fibrosis score was determined according to peritoneum morphology as follows: 0 = normal appearance with preserved mesothelial cells; 1 = mild change; 2 = moderate change; 3 = severe change, and 4 = whole peritoneal tissue showing fibrosis. The peritoneal cross-sections were observed by two investigators and averaged to determine the peritoneal thickness and fibrosis score.
Immunohistochemical Studies
Immunoperoxidase staining of peritoneal tissue was performed using 3-m formalin-fixed, paraffin-embedded sections, as described previously [6, 9] . The following antibodies were used as primary antibodies: (1) monoclonal mouse anti-4-hydroxy-2-nonenal (4-HNE) antibody (1: 100 dilution; NOF Corp., Tokyo); (2) monoclonal mouse anti-4-hydroxy-2-hexenal (4-HHE) antibody (1: 100 dilution; NOF Corp.), and (3) polyclonal rabbit antimouse type I collagen antibody (1: 200 dilution; Chemicon International, Inc., Temecula, Calif., USA) [6] . Immunostaining was conducted using the M.O.M. immunodetection kit (Vector Laboratories, Burlingame, Calif., USA). Diaminobenzidine was used as a chromogen. All slides were counterstained with hematoxylin. Normal mouse IgG or rabbit IgG was used as a negative control. The type I collagen scores and 4-HNE or 4-HHE staining scores were determined on the basis of the intensity and distribution of positive staining in the peritoneum: 0 = none; 1 = trace; 2 = mild; 3 = moderate, and 4 = severe staining. The scores were determined in ten randomly selected nonoverlapping ! 100 fields in each section.
Detection of 8-Hydroxy-2 -Deoxyguanosine (8-OHdG) in Peritoneal Fluid
Just before the time of sacrifice, 4 ml of saline was injected into the peritoneal cavity and then maintained there for 2 h. Each mouse was sacrificed by cervical dislocation under ether anesthesia. The remaining peritoneal fluid was drained, and then a laparotomy was performed to collect the residual intraperitoneal fluid and tissue samples. The total drainage volume was weighed, and the level of 8-OHdG, a marker for oxidative DNA damage, was determined by enzyme-linked immunosorbent assay using the 8-OHdG ELISA kit (Japan Institute for the Control of Aging, Shizuoka, Japan), as described previously [6] .
Statistical Analysis
Statistical analysis was performed using the StatView program (Hulinks, Tokyo). Data, shown as mean 8 SEM, were analyzed by the nonparametric Mann-Whitney U test for two comparisons. p ! 0.05 was taken to denote the presence of a statistically significant difference.
Results
Injection of the Higher Concentration of CG Markedly Increased Mortality in Acatalasemic Mice
Recently, the CG-induced peritoneal fibrosis model has been studied in several different rat and mouse strains [4, 5, 10] . However, the susceptibility to CG is supposed to vary among mouse strains. Initially, it was necessary to characterize this model in these mouse strains. In a pilot study, the intraperitoneal injection of the high concentration of CG (0.25%) induced a rapid increase in mortality in both mouse groups. In contrast, 40% of the acatalasemic mice survived 20 days after the injection of the lower concentrations of CG (0.15%), whereas all wildtype mice survived till 20 days ( fig. 1 ). These findings suggested that 0.15% of CG is a suitable concentration to investigate the effect of a functional catalase deficiency on peritoneal fibrosis. The body weight was similar between both groups at the start of the experiment, and there were no significant changes throughout the experiment in the setting of the lower concentration model at day 14 (wild-type mice 28.8 8 1.8 g; acatalasemic mice 28.0 8 1.2 g).
Acatalasemia Accelerates Peritoneal Fibrosis and Increases the Expression of Type I Collagen in Peritoneum
In wild-type and acatalasemic control mice, no histological abnormalities of the peritoneal tissue were observed at the light microscopic level ( fig. 2 a, b) . In acatalasemic mice, peritoneal fibrosis, detected as blue collagenous material by Azan-Mallory staining, developed 14 days after intraperitoneal CG injection and significantly increased in comparison with that observed in wild-type mice ( fig. 2 c, d, i) . To examine which extracellular matrix components increase in acatalasemic peritoneum with fibrosis, the expression of interstitial type I collagen was investigated by immunohistochemistry ( fig. 2 e-h) . A marked increase in the de novo expression of type I collagen was observed in the peritoneal thickness of the acatalasemic CG model in comparison to the wild-type CG model ( fig. 2 g, h, j) .
Peroxidation Products Increase in Peritoneal Tissue and Peritoneal Fluids in Acatalasemic Mice after Disease Induction
Oxidative stress may be a factor in stimulating peritoneal fibrosis in acatalasemic mice after injection of CG. Increased oxidative stress is known to damage cellular macromolecules including nuclear DNA and membrane lipids. The major content of the cell membrane is lipid, and therefore lipid peroxidation in tissues could cause peritoneal injury. The effect of acatalasemia on lipid peroxidation products in the submesothelial compact zone of the normal or injured peritoneum was examined. A moderate increase in 4-HNE or 4-HHE antibody labeling of various patches was observed in the thickening of the peritoneum in wild-type mice in comparison to control mice ( fig. 3 c, g ). More intense antibody binding was observed in the peritoneum of acatalasemic mice 14 days after injection of CG in comparison to wild-type mice ( fig. 3 d, h ). Control peritoneum showed only a slight antibody reaction ( fig. 3 a, b, e, f) . The extent of DNA damage in peritoneal mesothelial cells has been evaluated by examination of 8-OHdG in the peritoneal fluid. In acatalasemic mice, 14 days after injection of CG, the peritoneal excretion of 8-OHdG was markedly increased in comparison to wild-type mice ( fig. 3 k) .
GPX Does Not Compensate for Catalase in Acatalasemic Peritoneum
The maintenance of tissue homeostasis requires an appropriate balance between oxidants and antioxidants. Two major antioxidant enzymes, catalase and GPX, are physiologically involved in the degradation of H 2 O 2 and protect cells and tissues from oxidant-mediated injury. Therefore, the ability of other antioxidant enzymes to compensate for catalase in acatalasemic peritoneal fibrosis was examined in disease conditions. In wild-type mice, the peritoneal content of all three enzymes, including catalase, GPX, and SOD, was relatively low in comparison to other organs such as the kidney. The catalase activity in the peritoneum from the acatalasemic mice exhibited a 2.2-fold decrease in comparison to wild-type mice (p ! 0.05) and remained low 14 days after CG injection ( fig. 4 a) . Since high catalase levels are found in erythrocytes [11] , the catalase activity was compared between systemic saline-perfused and unperfused peritonea after removal of residual blood. The catalase activity of the perfused peritoneum was 5.7 8 0.4% lower than that of the unperfused peritoneum [12] . To examine the effect of acatalasemia on other peritoneal antioxidant enzymes in peritoneal fibrosis, the activities of GPX and SOD were measured in wildtype or acatalasemic mice. There was not any compensatory upregulation of GPX in the acatalasemic fibrotic peritonea or a significant difference in GPX activities between the two groups of mice ( fig. 4 b) . The level of SOD activity was unchanged in wild-type CG-treated mice during the development of peritoneal fibrosis. There was a significant upregulation of the activity of this enzyme in the acatalasemic CG-treated group ( fig. 4 c) . Since SOD catalyzes the conversion of superoxide anion radical to H 2 O 2 and O 2 , it is suggested that this upregulation may increase the level of H 2 O 2 in the peritoneum of acatalasemic CG-treated mice. The basal activities of GPX and SOD in the peritoneum were not significantly different between wild-type and acatalasemic mice.
Discussion
This study explored the effects of functional catalase deficiency on peritoneal tissue injury using an acatalasemic mouse strain and an experimental model of perito- neal sclerosis induced by repeated injection of CG. The results showed that acatalasemic mice developed more severe oxidant tissue injury and peritoneal fibrosis in comparison to wild-type mice in a CG-induced experimental peritoneal sclerosis model. Therefore, catalase, an antioxidant enzyme, may play a crucial role in the protection from peritoneal tissue injury and fibrosis. Rat peritoneal mesothelial cells spontaneously release H 2 O 2 in culture [13] . The process is significantly increased by the addition of phorbol myristate acetate or SOD to the medium, whereas it was substantially inhibited by catalase. The exposure of mesothelial cells to a high-glucose PD solution (4.25%) significantly stimulated H 2 O 2 generation, suggesting that increased H 2 O 2 generation in response to high glucose concentrations may induce peritoneal mesothelial cell injury [13] . A high glucose concentration induces collagen cross-linking between lysine residues possibly via H 2 O 2 in vitro and in vivo, and the effects were preventable by the addition of catalase [14] . Another antioxidant, N-acetylcysteine, significantly prevented peritoneal fibrosis and membrane hyperpermeability in rats after intraperitoneal administration of a conventional PD solution for 12 weeks [15] . The most important factor responsible for peritoneal deterioration in PD seems to be GDPs, which stimulate the production of components of the extracellular matrix as well as the synthesis of growth factors, including transforming growth factor beta and vascular endothelial growth factor, through the formation of advanced glycation end products (AGEs) [16] . Indeed, carboxymethyllysine formed from GDPs, localizes to the mesothelial layer and vascular walls of the peritoneal membrane of nondiabetic patients undergoing PD [17] . Furthermore, AGEs can mediate their effects via specific receptors, such as the receptor for AGE (RAGE), activating various signal transduction pathways, including the generation of ROS. The sources of ROS in the AGE/RAGE system include mitochondria, auto-oxidation of glucose, and enzymatic pathways, including NADPH [18] . ROS also mediate signal amplification in the upregulation of high glucose-induced fibronectin via the activation of protein kinase C in cultured human peritoneal mesothelial cells [19] . Therefore, ROS could be central mediators inducing both experimental and human peritoneal fibrosis.
Angiotensin II has been shown to be upregulated during peritonitis episodes and it may contribute to peritoneal fibrosis [16] . Indeed, the angiotensin-converting enzyme inhibitor quinapril ameliorated the fibrotic change as well as the increased converting enzyme activities in parietal peritoneum in a CG-induced experimental peritoneal sclerosis model in mice (the same model as used in this study) [20] . Angiotensin II stimulates the activity of NADPH oxidase via the AT1 receptor to produce the superoxide anion H 2 O 2 and hydroxyl radicals, which are reported to exert effects on intracellular growth-related proteins and enzymes to mediate the final biological responses [21] . The angiotensin II receptor blocker losartan significantly prevented peritoneal fibrosis and membrane hyperpermeability with an upregulation of dialysate vascular endothelial growth factor and angiotensin II in rats after intraperitoneal administration of conventional PD solution [15] . ROS further mediates angiotensin II stimulation of certain important signals, such as epidermal growth factor receptor transactivation, p38 mitogen-activated protein kinase, and Akt. Feinstein et al. [22] established an acatalasemic mouse strain (Cs b ) from the progeny of X-ray-irradiated mice. They screened blood catalase levels and developed congenic control (C3H/AnL/Cs a ) and acatalasemic (C3H/ AnL/Cs b ) mouse strains. The tissues of acatalasemic mice express normal catalase mRNA levels in comparison with those of wild-type mice, thus suggesting that the mutation does not act at the level of gene transcription or mRNA stability, but rather at the level of mRNA translation and/or protein turnover. The mutation has been mapped to the mouse catalase structural gene on chromosome 2 ( Cat or Cas1 ), and it is expressed by a modification of the enzyme active site but not of the antigenic site [22] . Shaffer and Preston [23] identified a Gln-to-His substitution at amino acid position 11 (G-to-T transversion) in acatalasemic catalase cDNA. Since this amino acid is located within a region that forms the first major alpha helix in the amino-terminal arm of the catalase subunit, this may render the catalase molecule unstable in acatalasemic mice [23] . Wang et al. [24] cloned the cDNA of catalase from a hypocatalasemic mouse strain (Cs c ) and reported that it contains a missense point mutation at amino acid position 439, which leads to an Aspto-Ser substitution (A-to-G transversion) [24] . Acatalasemic mice are found to develop and grow normally and are apparently healthy up to 1 year of age. The mice are as fertile as wild-type mice. No obvious abnormalities are seen in the morphology of major organs, including the heart, liver, lung, kidney, and peritoneum. However, an enhanced incidence of liver tumors is reported in these mice treated with diethylnitrosamine, suggesting that the increased oxidative stress burden brought about by acatalasemia may be involved in hepatocarcinogenesis [25] . A new line of catalase null mice has been generated recently using a gene-targeting technique. However, the phenotype of these mice may not accurately reflect the human acatalasemic conditions, since patients with acatalasemia retain residual catalase activity in their tissues [26] .
Finally, experimental peritoneal fibrosis induced by intraperitoneal injection of CG in ethanol may not completely mimic the peritoneal sclerosis observed in patients on long-term PD. Various factors, including uremia-induced alteration of the peritoneal membrane, GDPs in peritoneal fluids, and peritonitis, are involved in clinical settings. Experimental studies on mice exclusively utilized a CG-induced peritoneal sclerosis model, most likely due to the technical difficulty of maintaining abdominal catheters inserted for a long period of time in mice. Further studies using other experimental models more relevant to peritoneal sclerosis in the clinical setting are thus called for.
In summary, a progressive peritoneal sclerosis model was established in acatalasemic mice by repeated intraperitoneal injections of CG. Consequently, future studies on the development of novel therapeutic strategies to suppress peritoneal fibrosis, including an overexpression of catalase [27] or detoxification of hydroxyl radicals by utilizing acatalasemic mice, should be conducted.
